Since 4 June, the eastern façade of GIP ARRONAX has been transformed into an open-air exhibition: “Theranostics, towards personalised nuclear medicine”. Near the Laënnec hospital, ten large format panels present this new therapeutic strategy against cancer.
On each panel, a brightly coloured image and a scientific word, nothing more. To find out more, visit the website www.10ans-arronax.fr using a QR code.
This exhibition presents the challenges in cancerology of the principle of theranostics (a contraction of the words “therapy” and “diagnosis”) which, thanks to nuclear medicine, combines a diagnostic test, which identifies patients likely to respond to a given treatment, with a detailed characterisation of the disease, particularly its molecular targets, in order to propose an individualised treatment and thus improve the chances of success.
This selection of panels is taken from a travelling exhibition designed in 2018 to mark the 10th anniversary of the Arronax cyclotron, a state-of-the-art technological facility for scientific research and the production of innovative radionuclides for nuclear medicine, located in St-Herblain (Loire-Atlantique). This high-energy, high-intensity accelerator is unique in Europe and aims to produce radioelements of interest for nuclear medicine and radiochemistry. Since 2018, Arronax has been contributing to clinical trials aimed at improving the therapeutic management and diagnosis of cancers. Within the SIRIC, GIP Arronax is more particularly involved in axes 3 and 4 Programme 1 to generate innovative radionuclides for the development of therapies.